Abstract:Pharmaceutical industry is challenged by the rising development costs, strict regulatory and environmental requirements all while racing to deliver complex molecules to market. The need to be the first-in-class brings about shorter lifetime to the launched products in favor of better functioning followers. In addition, a shift from large volume blockbusters towards small volume production of complex molecules presents a unique opportunity to challenge the status quo in pharmaceutical manufacturing. Traditional batch manufacturing, while foundational, presents hurdles in scaling and efficiency, particularly for demanding reactions. Continuous manufacturing has emerged as a promising alternative, delivering better control and uniformity of operating conditions, mirroring the efficiencies found in small-scale batch reactors. However, continuous manufacturing is not universally applicable. As a solution, a combination of the two into hybrid manufacturing processes, appears to fill this gap effectively. While the concept of hybrid manufacturing is not new, the current perspective adds an additional angle to the integration of both technologies. Authors propose to sustain the continuity of the operation for batch mode processes by decreasing the reactor size and increasing the level of automation. Furthermore, modular fabrication of smaller-footprint technological platforms is expected to synergize other advancements in the field, such as digitalization, automation, and standardization. As a result, a leap towards the implementation of advanced manufacturing to drive sustainability in pharmaceutical industry is more tangible than ever.

A pharma perspective on sustainability advantages through adoption of continuous flow

Enhanced sustainability with crystallization in continuous flow

Enhancing Efficiency and Sustainability: Unleashing the Potential of Continuous Flow in Multicomponent Reactions

Recent Advances in 3D Printing for Continuous Flow Chemistry

Sustainable flow approaches to active pharmaceutical ingredients

Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

Towards Antibiotic Synthesis in Continuous-Flow Processes

Mechanochemistry Can Reduce Life Cycle Environmental Impacts of Manufacturing Active Pharmaceutical Ingredients

Continuous-flow Photochemistry:An Expanding Horizon of Sustainable Technology

Driving sustainability through adoption of hybrid manufacturing in small molecule API production

New Progress of Fully Continuous Flow Reaction Technologies in Pharmaceutical Synthesis (20192022)

Automated Optimization of a Multistep, Multiphase Continuous Flow Process for Pharmaceutical Synthesis

Key Green Chemistry research areas from a pharmaceutical manufacturers’ perspective revisited

Recent Advances and Applications in High-Throughput Continuous Flow

Contribution of microreactor technology and flow chemistry to the development of green and sustainable synthesis

Highlights of the Recent Patent Literature: Continuous Chemistry in the Pharmaceutical Industry

Micro reactor and flow chemistry for industrial applications in drug discovery and development

Increasing the Sustainability of Pharmaceutical Grade Water Production

Industrial Applications of Green Solvents in Organic and Drug Synthesis for Sustainable Development of Chemical Process and Technologies

Challenges and Directions for Green Chemical Engineering—Role of Nanoscale Materials

The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology